What daiichi sankyo vietnam does

Daiichi Sankyo Vietnam Company Limited is a wholly-owned subsidiary of Japan's Daiichi Sankyo Co., Ltd., operating in the Vietnamese pharmaceutical market with a headquarters in Ho Chi Minh City and a representative office in Hanoi (opened January 9, 2024). The entity imports, stores, and distributes pharmaceutical products and provides medical information to healthcare professionals across Vietnam, supported by a 500m² GSP-certified warehouse in Long An Province with temperature-controlled storage (15–25°C) and a cold room (2–8°C) operated under Good Storage Practice certification from Vietnam's Drug Administration (December 2023). The company's business model centers on regulated pharmaceutical distribution and medical-information dissemination to prescribers, leveraging the parent group's product portfolio and brand equity. Publicly disclosed information is limited: no specific product brands, pricing structure, revenue figures, or customer segmentation are provided, and the entity has signed multiple MoUs and CSR partnerships (with Terumo Vietnam, Ajinomoto Vietnam, Vinacapital Foundation, and Save the Children) between 2023 and 2025 alongside recognition from JICA (14th JICA President Award, 2018) and a Certificate of Good Performance Award (2017).

Name

daiichi sankyo vietnam

Legal name

Daiichi Sankyo Vietnam Company Limited

Website

https://daiichisankyo.com.vn

Company type

Private

Operating status

Operating

Short description

Daiichi Sankyo Vietnam Company Limited is a wholly-owned subsidiary of Japan's Daiichi Sankyo Co., Ltd., importing, storing, and distributing pharmaceutical products and medical information to healthcare professionals across Vietnam through GSP-certified warehouse and office operations.

Ownership category

akta.pro rank

Product category

Pharmaceutical Distribution

NAICS

Drugs and Druggists' Sundries Merchant Wholesalers (424210), Refrigerated Warehousing and Storage (493120)

SIC

Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)

akta.pro primary industry

Health Supply Chain, Procurement & Access to Medicines (BPADAIAI)

akta.pro secondary industry

Pharmaceutical & Life Sciences Cold Chain Storage (2–8°C / CRT) (TLALABAF)

Keywords

• Pharmaceutical distribution
• Pharmaceutical products
• Healthcare solutions
• Cold chain storage
• Medical information services

Headquarters

HQ city

Ho Chi Minh City

HQ country

Vietnam

HQ region

Asia

Offices3 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Personnel, Operations, Marketing or Sales

Distribution channels1 record

Marketing channels1 record

Core offering

Daiichi Sankyo Vietnam imports, stores, and distributes pharmaceutical products of the Daiichi Sankyo Group to healthcare professionals and institutions in Vietnam. The company operates a GSP-certified warehouse facility with temperature-controlled and cold storage capabilities to ensure product integrity for antibiotics and biological medicines, and supports healthcare professionals with medical information and CSR programs in cardiovascular and adolescent healthcare.

Product overview

Daiichi Sankyo Vietnam Company Limited is a pharmaceutical company and Vietnamese subsidiary of the global Daiichi Sankyo Group. The company engages in importing, storing, and distributing pharmaceutical products in Vietnam. Based on the available source material, no specific pharmaceutical products, brand names, or product portfolio details were identified. The company operates a GSP-certified warehouse facility in Vinh Loc 2 Industrial Park, Long An Province, with temperature-controlled storage (15-25°C) and cold storage capabilities (2-8°C) for various pharmaceutical products including antibiotics and biological medicines. The company also maintains an office in Hanoi to expand operations in Northern Vietnam.

Differentiator

Problem solved

Functional benefit

Products and services

• Pharmaceutical Products (Daiichi Sankyo Group portfolio)

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Five partnerships are on record, tiered minor.

• Vinacapital Foundation (VCF)minorStrategic or Co-development Partner · 26 March 2025Sponsorship agreement to fund heart surgeries for children with congenital heart disease from underprivileged backgrounds under the Heartbeat Vietnam program
• Terumo Vietnam Medical EquipmentminorStrategic or Co-development Partner · 24 March 2025MoU to collaborate on advancing cardiovascular expertise in Vietnam, supporting healthcare professionals in updating their knowledge and skills in interventional cardiology
• Ajinomoto VietnamminorStrategic or Co-development Partner · 20 December 2023MoU for developing special menus for ALS patients, with Ajinomoto providing nutrition expertise and menu development while Daiichi Sankyo connects with hospitals and patients
• Save the ChildrenminorStrategic or Co-development Partner · 4 July 2023Collaboration on Improving Adolescent Sexual and Reproductive Healthcare project in Yen Bai province, implemented over 20 months from July 2023 to March 2025
• Japan International Cooperation Agency (JICA)minorStrategic or Co-development PartnerFive-year cooperation (until March 2018) for Vietnam POLYVAC Measles-Rubella vaccine production technology transfer project

Scale indicators1 record

Recent moves7 records

Expansion highlights4 records

Direct peers

• AstraZeneca Vietnam: Multinational pharmaceutical subsidiary in Vietnam importing, distributing, and promoting a portfolio of innovative drugs to healthcare professionals. Operates with a similar GxP-compliant distribution model and hospital/specialist channel focus as Daiichi Sankyo Vietnam.
• Pfizer Vietnam: US pharma multinational's Vietnamese subsidiary engaged in import, storage, and distribution of branded pharmaceuticals across multiple therapeutic areas with comparable regulatory and channel dynamics to Daiichi Sankyo Vietnam.
• Novartis Vietnam: Swiss pharma multinational subsidiary in Vietnam distributing innovative specialty medicines with a similar hospital-channel and KOL engagement model. Comparable scale of subsidiary operations and product portfolio breadth.
• Roche Vietnam: Roche's Vietnamese subsidiary focused on oncology and specialty pharmaceuticals with cold-chain distribution needs. Comparable GSP-licensed infrastructure and direct-to-hospital specialist engagement.
• Sanofi Vietnam: French pharma multinational subsidiary in Vietnam with broad prescription and consumer health distribution, sharing the same GxP-compliant distribution, regulatory affairs, and CSR-driven market access approach.
• GSK Vietnam: UK pharma multinational subsidiary distributing vaccines, specialty, and general medicines in Vietnam. Overlaps directly with Daiichi Sankyo Vietnam's hospital-channel and GSP-certified cold chain distribution profile.
• Bayer Vietnam: German pharma multinational's Vietnam subsidiary covering prescription pharmaceuticals with cardiovascular focus, comparable in therapeutic area overlap (cardiovascular) and Vietnamese distribution scale.
• MSD (Merck) Vietnam: US pharma multinational subsidiary distributing vaccines, oncology, and specialty products in Vietnam with similar regulatory-driven market access strategies and GSP-compliant warehousing needs.
• Takeda Vietnam: Japanese pharma multinational subsidiary — closest analog given shared Japanese parentage and Southeast Asia strategy — operating in specialty, rare disease, and gastroenterology with similar regulatory and cultural operating context.

Emerging players

• DKSH Vietnam (Pharma Distribution): Contract pharmaceutical distributor in Vietnam offering GxP-compliant warehousing and last-mile services to pharma principals. Comparable in cold-chain storage and regulatory infrastructure even though not a subsidiary of a single manufacturer.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks4 records

Key highlights6 records

Customer concentration

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about daiichi sankyo vietnam